Results 151 to 160 of about 823,603 (291)

Beyond Bandung and Belgrade: Damodar Dharmananda Kosambi, A Forgotten Indian Voice for World Peace

open access: yesPeace &Change, Volume 51, Issue 2, Page 119-127, April 2026.
ABSTRACT Dr. Damodar Dharmananda Kosambi (1907–1966) was an Indian polymath best known for his intellectual contributions in a dizzyingly wide range of fields: mathematics, statistics, genetics, numismatics, history, and literature. His enduring reputation seems to have been posthumously sealed as the father of Marxist historiography in India. What has
Suchintan Das
wiley   +1 more source

Introduction: The (Im)material Spectrum of Manuscript and Print Interaction☆

open access: yesRenaissance Studies, Volume 40, Issue 2, Page 148-165, April 2026.
Abstract This introductory essay to the special issue on Early Modern English Textual Cultures Between Manuscript and Print first outlines previous research into different kinds of interaction between manuscript and print. Examples of this interplay include, for instance, the transmission of text and images from one medium into another, the use of ...
Sara Norja, Mari‐Liisa Varila
wiley   +1 more source

Print Conventions and Authority in Three English Recipe Manuscripts

open access: yesRenaissance Studies, Volume 40, Issue 2, Page 231-253, April 2026.
Abstract This article considers the uses of stylistic and visual conventions drawn from print books in three seventeenth‐ and eighteenth‐century recipe manuscripts at the University of Pennsylvania. We begin by analysing the title page, dedicatory epistle, catchwords, and headers of MS Codex 627, which imitates an edition of Hugh Plat's Delights for ...
Aylin Malcolm, Margaret C. Maurer
wiley   +1 more source

Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling—The CATCH experience

open access: yesInternational Journal of Cancer, Volume 158, Issue 6, Page 1675-1689, 15 March 2026.
What's new? CATCH is a prospective precision oncology registry trial that harnesses whole‐genome/exome‐ and RNA‐sequencing to enable actionable biomarker detection in metastatic breast cancer patients of any subtype. The data of the first 412 consecutive patients with completed follow‐up in this real‐world, single‐center patient cohort provide robust ...
Mario Hlevnjak   +31 more
wiley   +1 more source

Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107

open access: yesMolecular Oncology, Volume 20, Issue 3, Page 779-803, March 2026.
Clinical trials on PARP inhibitors in urothelial carcinoma (UC) showed limited efficacy and a lack of predictive biomarkers. We propose SLFN5, SLFN11, and OAS1 as UC‐specific response predictors. We suggest Talazoparib as the better PARP inhibitor for UC than Olaparib.
Jutta Schmitz   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy